High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects - Nature Biotechnology

日本 ニュース ニュース

High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects - Nature Biotechnology
日本 最新ニュース,日本 見出し
  • 📰 NatureBiotech
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 63%

High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects

We thank M.-m. Poo for helpful discussions and insightful comments on this manuscript; H. Yang and B. Wang from Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, for helpful discussions and technical assistance; L.-L. Chen from CAS Center for Excellence in Molecular Cell Science for the gift of the RanCas13b and dRanCas13b plasmids; and Y. Wang, Y. Zhang and Q. Hu from the Optical Imaging facility and S. Qian, H. Wu and L.

Jia Huang, Qingquan Xiao, Bingbing He, Xue Dong, Yuanhua Liu, Dingyi Han, Zikang Wang, Xuchen Wang, Wenqin Ying, Runze Zhang, Yu Wei, Chunlong Xu, Yingsi Zhou, Minqing Cai, Qifang Wang, Mingxing Xue, Guoling Li, Kailun Fang, Hainan Zhang & Hui YangJia Huang, Qingquan Xiao, Dingyi Han, Xuchen Wang, Runze Zhang & Yu Wei

Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Provincial Colleges and Universities, Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, ChinaShanghai Research Center for Brain Science and Brain-Inspired Intelligence, Shanghai, ChinaZhoupu Hospital Affiliated to Shanghai Health Medical College and Shanghai Key Laboratory of MolecularImaging, Shanghai,...

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

NatureBiotech /  🏆 231. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Associate or Senior Editor, Nature BiotechnologyAssociate or Senior Editor, Nature BiotechnologyWe're seeking a talented immunologist to join us as an Associate or Senior Editor. The deadline for applications is August 29, 2022
続きを読む »

mRNA printers kick-start personalized medicines for all - Nature BiotechnologymRNA printers kick-start personalized medicines for all - Nature BiotechnologymRNA printers will bring low-cost vaccines and made-to-order treatments for a range of different diseases.
続きを読む »

Nature Biotechnology - Single-cell-type tissue proteomicsNature Biotechnology - Single-cell-type tissue proteomicsThe August issue is live Our cover features an artistic impression of Deep Visual Proteomics, a method based on a combination of imaging, deep learning and mass spectrometry
続きを読む »

BA.5 wave on downturn in King County, but numbers still highBA.5 wave on downturn in King County, but numbers still highThe COVID surge caused by the BA.5 variant is on the downward side in King County, but health leaders warn that cases are still too high for comfort.
続きを読む »

Uprated Lamborghini Urus breaks Pikes Peak hillclimb record | AutocarUprated Lamborghini Urus breaks Pikes Peak hillclimb record | AutocarThe new Lamborghini Urus is the fastest production SUV to scale the Pikes Peak hill climb, beating the record by 17 seconds ⏱🔥
続きを読む »

Updated Lamborghini Urus climbs Pikes Peak in record timeUpdated Lamborghini Urus climbs Pikes Peak in record timeLamborghini has 2 new Urus variants coming in 2022.
続きを読む »



Render Time: 2025-03-07 09:38:23